Evidence map›Paper›PMID 30614086›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2019

Biologically Inspired, Cell-Selective Release of Aptamer-Trapped Growth Factors by Traction Forces.

Anna Stejskalová, Nuria Oliva, Frances J England, Benjamin D Almquist

Open access · hybridAbstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. A practical toolbox for modelling fibrosis in vitro.Nature biomedical engineering · 2026
    Review
  3. Mechanically Triggered DNA Nanovehicles for Targeted Dual-Drug Cancer Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Aptamers in Drug Delivery Development.Materials today (Kidlington, England) · 2025
    Article
  5. Cell-Instructive Biomaterials with Native-Like Biochemical Complexity.Annual review of biomedical engineering · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Force-Triggered Self-Destructive Hydrogels.Advanced materials (Deerfield Beach, Fla.) · 2023
    Article
  11. DNA Nanotechnology for Investigating Mechanical Signaling in the Immune System.Angewandte Chemie (International ed. in English) · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Anna StejskalováDepartment of Bioengineering, Imperial College London, London, SW7 2AZ, UK.ORCID https://orcid.org/0000-0003-4813-6452
Nuria OlivaDepartment of Bioengineering, Imperial College London, London, SW7 2AZ, UK.
Frances J EnglandDepartment of Bioengineering, Imperial College London, London, SW7 2AZ, UK.
Benjamin D AlmquistDepartment of Bioengineering, Imperial College London, London, SW7 2AZ, UK.
Imperial College London · GBInstitut Químic de Sarrià · ES

Funding

BIOSTATISTICS: MODELING AND INFERENCER01CA041628 · NCI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI OLSHEN, RICHARD ALLEN · 1985 to 1990
–
Department of Bioengineering at Imperial College LondonEngineering and Physical Science Research Council EP/R041628/1Marie Skłodowska-Curie grant 712949Wellcome Trust 109838Wellcome Trust 109838/Z/15/Z
6 · The paper itself

Abstract

Biomaterial scaffolds that are designed to incorporate dynamic, spatiotemporal information have the potential to interface with cells and tissues to direct behavior. Here, a bioinspired, programmable nanotechnology-based platform is described that harnesses cellular traction forces to activate growth factors, eliminating the need for exogenous triggers (e.g., light), spatially diffuse triggers (e.g., enzymes, pH changes), or passive activation (e.g., hydrolysis). Flexible aptamer technology is used to create modular, synthetic mimics of the Large Latent Complex that restrains transforming growth factor-β1 (TGF-β1). This flexible nanotechnology-based approach is shown here to work with both platelet-derived growth factor-BB (PDGF-BB) and vascular endothelial growth factor (VEGF-165), integrate with glass coverslips, polyacrylamide gels, and collagen scaffolds, enable activation by various cells (e.g., primary human dermal fibroblasts, HMEC-1 endothelial cells), and unlock fundamentally new capabilities such as selective activation of growth factors by differing cell types (e.g., activation by smooth muscle cells but not fibroblasts) within clinically relevant collagen sponges.

Indexed as

Aptamers, NucleotideTissue ScaffoldsBiomechanical PhenomenaBiomimetic MaterialsCell AdhesionCells, CulturedDermisElasticityEndothelial CellsFibroblastsHumansIntercellular Signaling Peptides and ProteinsMyocytes, Smooth MuscleNanotechnologyAptamers, NucleotideIntercellular Signaling Peptides and Proteinsaptamersbiomaterialsbiomimeticscontrolled releasegrowth factor deliverymechanobiology

Identifiers

PMID30614086
PMCPMC6375388
OpenAlexW2907726782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.